129 related articles for article (PubMed ID: 19723063)
1. Monitoring of long-term effects of resveratrol on cell cycle progression of human HeLa cells after administration of a single dose.
Kramer MP; Wesierska-Gadek J
Ann N Y Acad Sci; 2009 Aug; 1171():257-63. PubMed ID: 19723063
[TBL] [Abstract][Full Text] [Related]
2. Roscovitine differentially affects asynchronously growing and synchronized human MCF-7 breast cancer cells.
Maurer M; Komina O; Wesierska-Gadek J
Ann N Y Acad Sci; 2009 Aug; 1171():250-6. PubMed ID: 19723062
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells.
Wesierska-Gadek J; Kramer MP; Maurer M
Food Chem Toxicol; 2008 Apr; 46(4):1327-33. PubMed ID: 17933449
[TBL] [Abstract][Full Text] [Related]
4. Action of resveratrol alone or in combination with roscovitine, a CDK inhibitor, on cell cycle progression in human HL-60 leukemia cells.
Komina O; Wesierska-Gadek J
Biochem Pharmacol; 2008 Dec; 76(11):1554-62. PubMed ID: 18761329
[TBL] [Abstract][Full Text] [Related]
5. Impact of roscovitine, a selective CDK inhibitor, on cancer cells: bi-functionality increases its therapeutic potential.
Wesierska-Gadek J; Borza A; Komina O; Maurer M
Acta Biochim Pol; 2009; 56(3):495-501. PubMed ID: 19724778
[TBL] [Abstract][Full Text] [Related]
6. Outcome of treatment of human HeLa cervical cancer cells with roscovitine strongly depends on the dosage and cell cycle status prior to the treatment.
Wesierska-Gadek J; Borza A; Walzi E; Krystof V; Maurer M; Komina O; Wandl S
J Cell Biochem; 2009 Apr; 106(5):937-55. PubMed ID: 19180585
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle arrest induced in human breast cancer cells by cyclin-dependent kinase inhibitors: a comparison of the effects exerted by roscovitine and olomoucine.
Wesierska-Gadek J; Gueorguieva M; Wojciechowski J; Horky M
Pol J Pharmacol; 2004; 56(5):635-41. PubMed ID: 15591654
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells.
Ahmad N; Adhami VM; Afaq F; Feyes DK; Mukhtar H
Clin Cancer Res; 2001 May; 7(5):1466-73. PubMed ID: 11350919
[TBL] [Abstract][Full Text] [Related]
9. Pleiotropic effects of selective CDK inhibitors on human normal and cancer cells.
Wesierska-Gadek J; Hajek SB; Sarg B; Wandl S; Walzi E; Lindner H
Biochem Pharmacol; 2008 Dec; 76(11):1503-14. PubMed ID: 18761330
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells.
Sareen D; van Ginkel PR; Takach JC; Mohiuddin A; Darjatmoko SR; Albert DM; Polans AS
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3708-16. PubMed ID: 16936077
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol arrests cell cycle and induces apoptosis in human hepatocellular carcinoma Huh-7 cells.
Liao PC; Ng LT; Lin LT; Richardson CD; Wang GH; Lin CC
J Med Food; 2010 Dec; 13(6):1415-23. PubMed ID: 20946021
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Bhat KP; Pezzuto JM
Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
[TBL] [Abstract][Full Text] [Related]
13. Dual action of cyclin-dependent kinase inhibitors: induction of cell cycle arrest and apoptosis. A comparison of the effects exerted by roscovitine and cisplatin.
Wesierska-Gadek J; Gueorguieva M; Horky M
Pol J Pharmacol; 2003; 55(5):895-902. PubMed ID: 14704484
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis.
Kuwajerwala N; Cifuentes E; Gautam S; Menon M; Barrack ER; Reddy GP
Cancer Res; 2002 May; 62(9):2488-92. PubMed ID: 11980638
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro.
Lanzilli G; Fuggetta MP; Tricarico M; Cottarelli A; Serafino A; Falchetti R; Ravagnan G; Turriziani M; Adamo R; Franzese O; Bonmassar E
Int J Oncol; 2006 Mar; 28(3):641-8. PubMed ID: 16465368
[TBL] [Abstract][Full Text] [Related]
16. Interference with ER-α enhances the therapeutic efficacy of the selective CDK inhibitor roscovitine towards ER-positive breast cancer cells.
Węsierska-Gądek J; Gritsch D; Zulehner N; Komina O; Maurer M
J Cell Biochem; 2011 Apr; 112(4):1103-17. PubMed ID: 21308739
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells.
Wang TT; Schoene NW; Kim YS; Mizuno CS; Rimando AM
Mol Nutr Food Res; 2010 Mar; 54(3):335-44. PubMed ID: 20077416
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines.
Joe AK; Liu H; Suzui M; Vural ME; Xiao D; Weinstein IB
Clin Cancer Res; 2002 Mar; 8(3):893-903. PubMed ID: 11895924
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells.
Bernhaus A; Ozsvar-Kozma M; Saiko P; Jaschke M; Lackner A; Grusch M; Horvath Z; Madlener S; Krupitza G; Handler N; Erker T; Jaeger W; Fritzer-Szekeres M; Szekeres T
Invest New Drugs; 2009 Oct; 27(5):393-401. PubMed ID: 18841326
[TBL] [Abstract][Full Text] [Related]
20. Phenol red reduces ROSC mediated cell cycle arrest and apoptosis in human MCF-7 cells.
Wesierska-Gadek J; Schreiner T; Gueorguieva M; Ranftler C
J Cell Biochem; 2006 Aug; 98(6):1367-79. PubMed ID: 16741967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
